Healthcare provider profile · identity verified

Steven Michael Collins, M.D.

Family Practice · BELMONT, NY · NPI 1598719106

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	382	104
Omeprazole	Omeprazole	345	87
Lisinopril	Lisinopril	323	88
Atorvastatin Calcium	Atorvastatin Calcium	247	70
Metoprolol Succinate	Metoprolol Succinate	226	66
Gabapentin	Gabapentin	222	46
Amlodipine Besylate	Amlodipine Besylate	209	56
Levothyroxine Sodium	Levothyroxine Sodium	190	44
Tamsulosin Hcl	Tamsulosin Hcl	177	55
Meloxicam	Meloxicam	159	37
Prednisone	Prednisone	140	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	135	37
Fluticasone Propionate	Fluticasone Propionate	126	44
Losartan Potassium	Losartan Potassium	121	30
Albuterol Sulfate Hfa	Albuterol Sulfate	118	41
Alprazolam	Alprazolam	112	34
Simvastatin	Simvastatin	106	28
Citalopram Hbr	Citalopram Hydrobromide	97	19
Metformin Hcl	Metformin Hcl	96	27
Eliquis	Apixaban	94	17
Famotidine	Famotidine	94	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	92	22
Pantoprazole Sodium	Pantoprazole Sodium	88	19
Tramadol Hcl	Tramadol Hcl	84	22
Allopurinol	Allopurinol	78	19
Hydrochlorothiazide	Hydrochlorothiazide	78	23
Trazodone Hcl	Trazodone Hcl	71	18
Furosemide	Furosemide	63	17
Metformin Hcl Er	Metformin Hcl	60	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	16
Finasteride	Finasteride	58	16
Triamcinolone Acetonide	Triamcinolone Acetonide	58	31
Atenolol	Atenolol	57	12
Fluoxetine Hcl	Fluoxetine Hcl	54	14
Alendronate Sodium	Alendronate Sodium	50	17
Pravastatin Sodium	Pravastatin Sodium	50	15
Potassium Chloride	Potassium Chloride	49	12
Glipizide	Glipizide	46	12
Metoprolol Tartrate	Metoprolol Tartrate	45	14
Azithromycin	Azithromycin	43	26
Spironolactone	Spironolactone	43	11
Ozempic	Semaglutide	41	suppressed
Januvia	Sitagliptin Phosphate	40	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Jardiance	Empagliflozin	37	suppressed
Pregabalin	Pregabalin	37	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	13
Benazepril Hcl	Benazepril Hcl	33	suppressed
Naproxen	Naproxen	33	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	13
Sertraline Hcl	Sertraline Hcl	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	20
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	21	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Torsemide	Torsemide	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	16
Dutasteride	Dutasteride	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	11
Valsartan	Valsartan	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Fentanyl	Fentanyl	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Levetiracetam	Levetiracetam	14	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Ajovy Autoinjector	Fremanezumab-Vfrm	11	suppressed
Carvedilol	Carvedilol	11	suppressed
Digoxin	Digoxin	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Nexium	Esomeprazole Magnesium	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Ramipril	Ramipril	11	suppressed
Ropinirole Er	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error